| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f0cb3ff6fb82d7809e8cbcd11bb44de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50de4ade4243357e275c1ca577bded9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39b620363843d772538eca74ae87e8e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ac83473f7597d2efd095aaea3fddb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7d999bb6ab478a7ed29b45a75d9190d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01850818656e68f1f33ce7e066d1b973
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c929d9ee25d9b0ef3aeaefc95cdaa9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d6e013e799d922625013929ada8779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e2e5ca228a68e3bcad53b35a6e15fe |
| publicationDate |
2009-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009016385-A1 |
| titleOfInvention |
Methods of aiding in the diagnosis of prostate cancer |
| abstract |
A method for aiding in the assessment of prostate cancer (including metastatic prostate cancer) and/or benign prostate hyperplasia in a patient, the method comprising the step of determining the level of CNP nucleic acid and/or protein in a sample from the patient. The patient may be at risk of developing prostate cancer, or have already been diagnosed with prostate cancer, or may have undergone treatment for prostate cancer. The method may be for assessing the likely progression of prostate cancer in the patient, or for assessing prostate function, or for assessing and/or predicting the development of prostate cancer. The method may be for diagnosing prostate cancer in the patient or for assessing the response of the patient to treatment for prostate cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3088416-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110517765-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9857382-B2 |
| priorityDate |
2007-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |